Guidance for Industry: Potency Assurance for Cellular and Gene Therapy Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 2, 2026
November 2, 2026
b0c71ebb-a023-4038-8713-7a43757441d1
Related Documents
Human Gene Therapy for Rare Diseases: Guidance for Industry
Guidance DocumentJanuary 28, 2020Center for Biologics Evaluation and Research
Preclinical Assessment of Investigational Cellular and Gene Therapy Products: Guidance for Industry
Guidance DocumentNovember 1, 2013Center for Biologics Evaluation and Research
Human Gene Therapy for Hemophilia: Guidance for Industry
Guidance DocumentJanuary 28, 2020Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.